Comparison

RG7112 European Partner

Item no. TMO-T6965-10mM
Manufacturer TargetMol
CASRN 939981-39-2
Amount 1 mL x 10 mM (in DMSO)
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Veronica Tisato, et al. MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer. Journal of Hematology & Oncology2017
Smiles CCOc1cc(ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias RG-7112,RG 7112,RO5045337
Shipping Condition Cool pack
Available
Manufacturer - Targets
E1/E2/E3 Enzyme|||Mdm2
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
727.78
Description
RG7112 (RO5045337) (RO5045337) is an orally bioavailable and selective p53-MDM2 inhibitor.
Pathways
Apoptosis|||Ubiquitination
Bioactivity
RG7112 (RO5045337) is an orally bioavailable and selective p53-MDM2 inhibitor. Phase 1.
Receptor
Mdm2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL x 10 mM (in DMSO)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close